Ding K - Search Results

1

Targeting EGFR^L858R/T790M and EGFR^{L858R/T790M/C797S} resistance mutations in NSCLC: Current developments in medicinal chemistry.

Lu X, Yu L, Zhang Z, Ren X, Smaill JB, Ding K. Lu X, et al. Among authors: ding k. Med Res Rev. 2018 Sep;38(5):1550-1581. doi: 10.1002/med.21488. Epub 2018 Jan 26. Med Res Rev. 2018. PMID: 29377179 Review.

2

Atovaquone derivatives as potent cytotoxic and apoptosis inducing agents.

Zhou J, Duan L, Chen H, Ren X, Zhang Z, Zhou F, Liu J, Pei D, Ding K. Zhou J, et al. Among authors: ding k. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5091-4. doi: 10.1016/j.bmcl.2009.07.044. Epub 2009 Jul 10. Bioorg Med Chem Lett. 2009. PMID: 19632833

3

A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton.

Zhang J, Zhou J, Ren X, Diao Y, Li H, Jiang H, Ding K, Pei D. Zhang J, et al. Among authors: ding k. Invest New Drugs. 2012 Apr;30(2):490-507. doi: 10.1007/s10637-010-9577-1. Epub 2010 Nov 16. Invest New Drugs. 2012. PMID: 21080210

4

Hybrid compounds as new Bcr/Abl inhibitors.

Wang D, Zhang Z, Lu X, Feng Y, Luo K, Gan J, Yingxue L, Wan J, Li X, Zhang F, Tu Z, Cai Q, Ren X, Ding K. Wang D, et al. Among authors: ding k. Bioorg Med Chem Lett. 2011 Apr 1;21(7):1965-8. doi: 10.1016/j.bmcl.2011.02.029. Epub 2011 Feb 13. Bioorg Med Chem Lett. 2011. PMID: 21376587

5

Recent developments in the third generation inhibitors of Bcr-Abl for overriding T315I mutation.

Lu XY, Cai Q, Ding K. Lu XY, et al. Among authors: ding k. Curr Med Chem. 2011;18(14):2146-57. doi: 10.2174/092986711795656135. Curr Med Chem. 2011. PMID: 21517764 Review.

6

Identification of pyrido[1,2-α]pyrimidine-4-ones as new molecules improving the transcriptional functions of estrogen-related receptor α.

Peng L, Gao X, Duan L, Ren X, Wu D, Ding K. Peng L, et al. Among authors: ding k. J Med Chem. 2011 Nov 10;54(21):7729-33. doi: 10.1021/jm200976s. Epub 2011 Oct 12. J Med Chem. 2011. PMID: 21958216

7

New thiazole carboxamides as potent inhibitors of Akt kinases.

Chang S, Zhang Z, Zhuang X, Luo J, Cao X, Li H, Tu Z, Lu X, Ren X, Ding K. Chang S, et al. Among authors: ding k. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1208-12. doi: 10.1016/j.bmcl.2011.11.080. Epub 2011 Nov 30. Bioorg Med Chem Lett. 2012. PMID: 22172705

8

Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.

Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K. Cheng H, et al. Among authors: ding k. J Med Chem. 2012 Mar 8;55(5):2144-53. doi: 10.1021/jm2013503. Epub 2012 Feb 27. J Med Chem. 2012. PMID: 22332894

9

Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine⁷⁹⁰ → methionine⁷⁹⁰ mutant.

Chang S, Zhang L, Xu S, Luo J, Lu X, Zhang Z, Xu T, Liu Y, Tu Z, Xu Y, Ren X, Geng M, Ding J, Pei D, Ding K. Chang S, et al. Among authors: ding k, ding j. J Med Chem. 2012 Mar 22;55(6):2711-23. doi: 10.1021/jm201591k. Epub 2012 Mar 1. J Med Chem. 2012. PMID: 22339342

10

Recent advance in the design of small molecular modulators of estrogen-related receptors.

Lu X, Peng L, Lv M, ding K. Lu X, et al. Among authors: ding k. Curr Pharm Des. 2012;18(23):3421-31. doi: 10.2174/138161212801227113. Curr Pharm Des. 2012. PMID: 22632982 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,703 results

Search Page